Tiacrilast sodium

This classification denotes a histamine-1 receptor antagonist C12H9N2O3S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4PG8A6UTDX, chemically known as sodium (e)-6-(methylthio)-4-oxo-3(4h)-quinazolineacrylate, monohydrate, but more generally known as tiacrilast sodium, which bears US NIH Compound Identifier 23665632. Most nations, for tariff and trade purposes, schedule tiacrilast sodium under HS 29335995 and SITC 51576. As of Q4 2014, TIACRILAST SODIUM remains US FDA's Preferred Term for this commodity. Tiacrilast sodium bears US NLM identifiers UMLS ID C2348786 and NCI Concept Code C72862. SMILES: CSC1CCC2C(C1)C(=O)N(CN2)/C=C/C(=O)[O-].O.[NA+].